UCL Department of Biochemical Engineering


Vax Hub Platform Funding

Call for proposals for feasibility studies now open


Members* of the Vax-Hub Users Group are invited to submit proposals for funding to support feasibility studies.  Funding of between £75,000 and £100,000 (including VAT, where applicable) per project is available.

Projects are expected to focus on research and development studies that lie within preparedness, technology readiness, rapid response activity or that draw on existing insights to test and validate solutions. Projects could draw on or develop current research, for example, that which was funded by the previously advertised Vax-Hub Interaction Voucher scheme or lay the foundations for more substantive future research.  All projects should have outcomes that primarily benefit LMI countries.  Users are expected to provide industry supervision to the project and provide access to the necessary materials, equipment or data.

Proposals may choose to focus on one or more of the following areas:

  • VLP vaccines
  • Formulation, thermostability
  • Glycoconjugated vaccines
  • Viral vectored vaccines
  • Health economics
  • Policy
  • Decisional tools (cost of goods, supply chain management, etc.)
  • Regulation

Application Process

Feasibility studies funding is awarded competitively. Applications will be via a one-stage process that will include the submission of an application form, work plan and costings. Proposals, including the budget application, should be developed by the user organisation(s) in collaboration with the academic partner/Hub researcher(s) if involved in the project.

To apply, please see further details in this document

and complete the following

(for the other formats please email vaxhub@ucl.ac.uk)

*Applications will be accepted from organisations that are in the process of joining the Hub and awards will be made subject to the completion of the required documentation by 27 July 2020.

Vax-Hub is pleased to announce the award of interaction vouchers to support the following collaborative activity.

PartnersProject title
Hilleman Labs & UCLEstablishing the use of microscale chromatography-for downstream process optimization of Group B streptococcus polysaccharides
Phenotypeca Ltd and the University of OxfordExploiting the genetic diversity of Saccharomyces cerevisiae for VLP production
Sartorius Stedim Biotech and the University of OxfordCost of goods evaluation of adenovirus-based vaccine against Coronavirus
Sartorius Stedim Biotech and the University of OxfordImproving scalability and productivity of an adenovirus-based vaccine against Coronavirus
Univercells, University of Leeds & UCLProof of principle synthesis of polio virus-like particles in an E. coli cell-free manufacturing platform
Vironova and UCLMiniTEM analysis: characterisation of Viral Vaccines, Vectors and VLPs

Vax-Hub membership

Platform funding will be awarded to members* of the Vax-Hub Users Group only.  If you are not currently a member of the Hub but would be interested in joining to access this and other Hub benefits, please contact Jane Doogan, Vax-Hub Project Manager: j.doogan@ucl.ac.uk